XML 45 R39.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used to Determine Grant-date Fair Value of Stock Options Granted

The following table presents, on a weighted-average basis, the assumptions used in the Black-Scholes option pricing model to determine the grant-date fair value of stock options granted:

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

Fair value of common stock

 

$

14.38

 

 

$

10.95

 

Risk-free interest rate

 

 

4.25

%

 

 

4.08

%

Expected term (in years)

 

 

5.97

 

 

 

6.02

 

Expected volatility

 

 

100.01

%

 

 

86.57

%

Expected dividend yield

 

 

0

%

 

 

0

%

Summary of Stock Options Activity

The following table summarizes stock option activity for the nine months ended September 30, 2025:

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Weighted-
Average

 

 

Average
Remaining

 

 

Aggregate

 

 

 

Number of
Options

 

 

Exercise
Price

 

 

Contractual
Term

 

 

Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding at December 31, 2024

 

 

5,667,555

 

 

$

6.98

 

 

 

7.6

 

 

$

22,929

 

Granted

 

 

1,731,539

 

 

$

17.85

 

 

 

 

 

 

 

Exercised

 

 

(462,107

)

 

$

6.04

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(156,340

)

 

$

9.95

 

 

 

 

 

 

 

Expired

 

 

(15,396

)

 

$

7.09

 

 

 

 

 

 

 

Outstanding at September 30, 2025

 

 

6,765,251

 

 

$

9.76

 

 

 

7.5

 

 

$

68,553

 

Vested and expected to vest at September 30, 2025

 

 

6,765,251

 

 

$

9.76

 

 

 

7.5

 

 

$

68,553

 

Options exercisable at September 30, 2025

 

 

3,536,423

 

 

$

7.74

 

 

 

6.6

 

 

$

42,854

 

Summary of Non-Vested Stock Options

The following table summarizes the non-vested stock options that were outstanding as of September 30, 2025 and December 31, 2024:

 

 

 

 

 

 

Weighted-
Average

 

 

 

Number of
Options

 

 

Exercise
Price

 

 

 

 

 

 

 

 

Non-vested options, September 30, 2025

 

 

3,228,828

 

 

$

11.97

 

Non-vested options, December 31, 2024

 

 

2,797,887

 

 

$

6.86

 

 

Summary of RSU Activity

The following table summarizes RSU activity under the Company's incentive plans for the nine months ended September 30, 2025:

 

 

 

 

 

 

Weighted-
Average

 

 

 

Number of Shares

 

 

Grant Date Fair Value

 

 

 

 

 

 

 

 

RSUs outstanding, December 31, 2024

 

 

 

 

$

 

Granted

 

 

1,056,299

 

 

$

14.69

 

Vested

 

 

(190,222

)

 

$

14.59

 

Cancelled

 

 

(41,306

)

 

$

14.52

 

RSUs outstanding, September 30, 2025

 

 

824,771

 

 

$

14.72

 

Schedule of Stock-Based Compensation Expense by Type and Financial Statement Line

Stock-based compensation expense by type and financial statement line is included in the Company’s statements of operations and comprehensive loss as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

 

(in thousands)

 

Options

 

$

3,116

 

 

$

1,976

 

 

$

8,721

 

 

$

4,832

 

RSUs

 

 

1,362

 

 

 

 

 

 

3,360

 

 

 

 

 Total stock-based compensation expense

 

$

4,478

 

 

$

1,976

 

 

$

12,081

 

 

$

4,832

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

 

(in thousands)

 

Cost of sales

 

$

140

 

 

$

69

 

 

$

399

 

 

$

201

 

Research and development

 

 

893

 

 

 

294

 

 

 

2,319

 

 

 

844

 

Sales and marketing

 

 

1,273

 

 

 

472

 

 

 

3,388

 

 

 

1,150

 

General and administrative

 

 

2,172

 

 

 

1,141

 

 

 

5,975

 

 

 

2,637

 

 Total stock-based compensation expense

 

$

4,478

 

 

$

1,976

 

 

$

12,081

 

 

$

4,832